|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenues | |||||
| Product revenues | |||||
| Service revenues | |||||
| Total revenues | |||||
| Cost of revenues | |||||
| Product revenues | |||||
| Service revenues | |||||
| Total cost of revenues | |||||
| Gross profit | |||||
| Operating expenses: | |||||
| Research and development, net | |||||
| Selling, general and administrative | |||||
| Total operating expenses | |||||
| Operating loss | |||||
| Other income (expense): | |||||
| Interest expense, net | |||||
| Interest expense | |||||
| Interest income | |||||
| Total interest expense, net | |||||
| Loss on foreign exchange | |||||
| Change in fair value of liability classified warrants | |||||
| Other income, net | |||||
| Total other income (expense), net | |||||
| Loss before income taxes | |||||
| Benefit (provision) for income taxes | |||||
| Net loss | |||||
| Other comprehensive income (loss), net of tax: | |||||
| Foreign currency translation gain (loss) | |||||
| Unrealized gain on available-for-sale marketable securities | |||||
| Comprehensive loss | |||||
| Net loss per share attributable to Rocket Lab Corporation: | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted-average common shares outstanding: | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...